Schroder Investment Management Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.69M	Sell	176,076 -13,866	-7%	-$706K	0.01%	693
2025 Q4	$9.48M	Buy	+189,942	New	+$9.24M	0.01%	647
2025 Q3	–	Sell	-266,927	Closed	-$8.41M	–	1261
2025 Q2	$8.41M	Sell	266,927 -2,553	-0.9%	-$81.8K	0.01%	666
2025 Q1	$8.7M	Sell	269,480 -29,177	-10%	-$1.03M	0.01%	663
2024 Q4	$11M	Sell	298,657 -216,640	-42%	-$7.63M	0.01%	642
2024 Q3	$15.8M	Buy	515,297 +7,200	+1%	+$225K	0.02%	578
2024 Q2	$13.6M	Buy	508,097 +150,416	+42%	+$4.36M	0.02%	572
2024 Q1	$12.2M	Sell	357,681 -184,292	-34%	-$5.49M	0.01%	609
2023 Q4	$15.7M	Buy	+541,973	New	+$14.4M	0.02%	538
2020 Q3	–	Sell	-1,360	Closed	-$32K	–	1388
2020 Q2	$32K	Sell	1,360 -10,900	-89%	-$241K	﹤0.01%	1200
2020 Q1	$224K	Sell	12,260 -881	-7%	-$18.5K	﹤0.01%	1088
2019 Q4	$312K	Buy	+13,141	New	+$319K	﹤0.01%	1112
2018 Q3	–	Sell	-15,343	Closed	-$895K	–	1335
2018 Q2	$895K	Buy	15,343 +76	+0.5%	+$3.94K	﹤0.01%	950
2018 Q1	$699K	Buy	15,267 +1,643	+12%	+$68.6K	﹤0.01%	1011
2017 Q4	$543K	Buy	13,624 +5,160	+61%	+$204K	﹤0.01%	1086
2017 Q3	$333K	Buy	+8,464	New	+$366K	﹤0.01%	1135